![A U1i RNA that Enhances HIV-1 RNA Splicing with an Elongated Recognition Domain Is an Optimal Candidate for Combination HIV-1 Gene Therapy: Molecular Therapy - Nucleic Acids A U1i RNA that Enhances HIV-1 RNA Splicing with an Elongated Recognition Domain Is an Optimal Candidate for Combination HIV-1 Gene Therapy: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/75458bf0-eaa1-434d-a3bf-409da23266f7/gr1_lrg.jpg)
A U1i RNA that Enhances HIV-1 RNA Splicing with an Elongated Recognition Domain Is an Optimal Candidate for Combination HIV-1 Gene Therapy: Molecular Therapy - Nucleic Acids
![A U1i RNA that Enhances HIV-1 RNA Splicing with an Elongated Recognition Domain Is an Optimal Candidate for Combination HIV-1 Gene Therapy: Molecular Therapy - Nucleic Acids A U1i RNA that Enhances HIV-1 RNA Splicing with an Elongated Recognition Domain Is an Optimal Candidate for Combination HIV-1 Gene Therapy: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/78cdf659-2c34-4f5c-9730-7948869a5673/gr3.jpg)
A U1i RNA that Enhances HIV-1 RNA Splicing with an Elongated Recognition Domain Is an Optimal Candidate for Combination HIV-1 Gene Therapy: Molecular Therapy - Nucleic Acids
![A U1i RNA that Enhances HIV-1 RNA Splicing with an Elongated Recognition Domain Is an Optimal Candidate for Combination HIV-1 Gene Therapy - ScienceDirect A U1i RNA that Enhances HIV-1 RNA Splicing with an Elongated Recognition Domain Is an Optimal Candidate for Combination HIV-1 Gene Therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2162253119303087-gr7.jpg)